Thomas Longerich
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Hepatitis C virus research
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Hepatology 63
- Hepatocellular Carcinoma Treatment and Prognosis 32
- Liver physiology and pathology 17
- Liver Disease and Transplantation 13
-
- Cancer Genomics and Diagnostics 14
- Co-authors
- Peter SchirmacherKai BreuhahnLars ZenderChristian TrautweinRobert GeffersFrank TackeTetyana YevsaVolker Ehemann
- Journals
- Hepatology (21 papers)Journal of Hepatology (18 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (6 papers)Scientific Reports (5 papers)Gut (5 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Thomas Longerich
202 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 144
- Hepatology 1.7k
- Cancer Research 1.8k
- Epidemiology 1.9k
- Oncology 1.4k
- Molecular Biology 3.3k
Countries citing papers authored by Thomas Longerich
This map shows the geographic impact of Thomas Longerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Longerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Longerich more than expected).
Fields of papers citing papers by Thomas Longerich
This network shows the impact of papers produced by Thomas Longerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Longerich. The network helps show where Thomas Longerich may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Longerich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 2 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 7 | |
| 8 | 2023 | 12 | |
| 9 | 2022 | 19 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 102 | |
| 13 | 2020 | 3 | |
| 14 | 2018 | 188 | |
| 15 | Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis Hit paper breakdown → | 2017 | 421 |
| 16 | 2017 | 46 | |
| 17 | 2016 | 12 | |
| 18 | 2015 | 114 | |
| 19 | 2014 | 31 | |
| 20 | Hochdifferenzierte Lebertumoren : Neue Entwicklungen und ihre diagnostische Relevanz (Meet the Expert) | 2009 | 1 |
About Thomas Longerich
Thomas Longerich is a scholar working on Hepatology, Cancer Research, Transplantation, Oncology and Epidemiology, having authored 205 papers that have together received 7.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (44 papers), Hepatocellular Carcinoma Treatment and Prognosis (32 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers), Liver physiology and pathology (17 papers), Cancer-related Molecular Pathways (17 papers), Cancer Genomics and Diagnostics (14 papers), Liver Disease and Transplantation (13 papers) and RNA modifications and cancer (12 papers). The work is most often cited by research in Hepatology (1.7k citations), Cancer Research (1.8k citations), Epidemiology (1.9k citations), Oncology (1.4k citations) and Molecular Biology (3.3k citations). Thomas Longerich has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Peter Schirmacher, Kai Breuhahn, Lars Zender, Christian Trautwein, Robert Geffers, Frank Tacke, Tetyana Yevsa, Volker Ehemann, Tom Luedde and Tim F. Greten. Their work appears in journals such as Hepatology, Journal of Hepatology, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, Scientific Reports and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.